Tub is a member of a small gene family, the tubby-like proteins (TULPs), with predominant expression in neurons. Mice carrying a mutation in Tub develop retinal and cochlear degeneration as well as late onset obesity with insulin resistance.
Introduction
The autosomal recessive mutation tubby (tub), mapping to Chr 7, occurred spontaneously in a C57BL/6J (B6) mouse (1) . Tubby homozygotes display a tripartite phenotype of blindness, deafness and maturity onset obesity (1, 11, 33) . Obesity in tubby mice is slowly progressive and tubby homozygous mice moderately increase their food intake as they gain weight (Nishina and Naggert, unpublished results). Plasma insulin levels also increase as the animals gain weight and normoglycemia is maintained throughout life. The tubby phenotype of sensory loss coupled with obesity and insulin resistance is similar to that found in two human syndromes, Alström (2) and Bardet-Biedl (17) .
The tubby mutation was identified as a G to T transversion in the splice donor site of the last intron of a novel gene, leading to the loss of the C-terminal amino acid sequence encoded by the last exon (16, 31 ) and consequently to a loss of tubby function (41) . The tubby gene is a member of a small gene family that also includes three tubby-like protein genes (Tulp1, Tulp2, and Tulp3) (30, 32) . The biochemical function of the TULPs is currently not fully understood. Roles as transcription factors (37) , as intermediates in insulin signaling (14) , or in intracellular transport (3, 7, 8) , have been proposed.
Although the mutation has been first described more than a decade ago, relatively little is known about the physiological abnormalities underlying the obesity in this model. Here we report that tubby mice have a low respiratory exchange ratio (respiratory quotient, RQ) that does not increase after feeding. This RQ abnormality is accompanied by changes in gene expression and altered metabolism in the liver that may contribute to the observed phenotype of slowly progressive moderate obesity. PG-00239-2005 .R1
Materials and Methods

Animals
Seven-week-old C57BL/6J.Cg -Tub tub /Jkn (B6-tub/tub) mice, as well as their heterozygote (B6-tub/+) and wildtype (B6-+/+) littermates were obtained from the Research Animal Facility at The Jackson Laboratory. For collecting the CLAMS TM data, homozygous B6.Cg-Hbb c Tub tub /J mice and control littermates were obtained from Jackson Research Systems. The mice were maintained on a NIH-31 mouse/rat diet with 4% fat (11% calories from fat, #5K54, PMI Feeds Inc., St. Louis, MO), fed ad libitum with free access to water (HCl acidified, pH 2.8-3.2) under controlled temperature and humidity with a 12-hour light and dark cycle (lights on from 6:00-18:00 hrs). Mice were killed between 16:00 -17:00 hours (light cycle sample) and between 23:00-24:00 hours (dark cycle sample) and liver and brain were harvested for RNA isolation and protein and enzymatic assays.
Comprehensive Laboratory Animal Monitoring System (CLAMS TM )
The Comprehensive Laboratory Animal Monitoring System (CLAMS TM , Columbus Instruments, Columbus, OH) is a set of live-in cages for automated, non-invasive and simultaneous monitoring of horizontal and vertical activity, feeding and drinking, oxygen consumption and CO 2 production. Seven to eight-week-old tubby mice and controls were placed in individual CLAMS TM cages between 11:30 a.m. and 1:00 p.m. on the first day of a 3-day test period. A 3-day test period allows examination of response to a novel environment from data collected on Day 1 and leaves two additional days for diurnal patterns to be established. Raw data from each mouse were converted from the archive format to Excel and Statistica files for examination and analysis, respectively. Raw data for each of the measures were plotted as a function of time over each of the three consecutive PG-00239-2005 . R1 24-hour periods. Mean values from each animal were examined for outliers in each measure relative to the control B6 mice at several different epochs. The epochs examined included exploratory, daily, light, and dark periods and the onset of 12-hour dark period relative to the final portion of the light period.
Data are collected in three files for each animal, including an activity file, bout file and total file.
The activity file displays all activity data recorded every 10 seconds over the 72-hour test period, where the bout file contains number and duration of bout activity during the test. The total file displays all measurements for each parameter (VO2, VCO2, RER, heat, accumulated feed, accumulated drink, XY total activity, XY ambulatory activity and Z activity). The parameters are recorded from a single cage during a 30-second period every hour, beginning with the first cage of the system and ending with the last cage in the circuit. An analysis software program was created to compare each parameter during the explore period (first three measurements after placement in the cage), post-explore period (next three measurements after placement in the cage), daily means, three measurements before lights are turned off (BF), three measurements after lights are turned off (AF), three measurements prior to lights turning on (BN) and three measurements after lights have been turned on (12) .
Real-time quantitative RT-PCR
Brain (hypothalamus), liver, muscle and adipose tissue were collected and immediately placed in liquid nitrogen. RNA was isolated using TRIZOL reagent (Life Technologies, CA) according to manufacturers recommendation. Total RNA was further treated with RNAse-free DNAse I (Ambion Inc., TX). RNA quality and quantity were evaluated by UV spectrophotometry and a total RNA Nano Assay (Agilent Technologies 2100 Bioanalyzer-Bio Sizing, Version A.02.01 S1232), respectively. PG-00239-2005.R1 Oligonucleotide sequences used for Real Time PCR assays, length of amplified fragment, and Genbank Accession No of the cDNA from which the primer sequence was derived are in Table 1 .
Real-time RT-PCR assays were performed as previously described (6, 34) . Real Time PCR primers for the quantitative detection of target mRNAs were designed using the Primer Express computer software (Applied Biosystems, CA). The real-time measurements were carried out on an ABI PRISM 7700 SDS instrument. Samples were analyzed in triplicate in three independent runs. Table 1 
Immunhistochemical analysis and quantitation of orexin by Elisa.
7-weeks-old mice (three B6-tub/tub and three B6-+/+) were anesthetized during the light period (16:00 hr) with tribromoethanol and perfused with phosphate buffered saline (PBS) followed by 4% paraformaldehyde (PFA) in PBS as fixative. Brains were post-fixed in the same fixative for 1-3 h, dehydrated and embedded in paraffin. Serial sections of 6 µm thickness were cut and mounted on slides pretreated with polylysine (Sigma, St. Louis, MO). Sections were deparaffinized in xylene and rehydrated through a graded series of alcohol and PBS. A microwave procedure was used for antigen retrieval (8 min in citrate buffer, pH 6-6.5). Slides were then incubated in 0.3% hydrogen peroxide for 30 min to inhibit endogenous peroxidase activity. After incubation with blocking solution (3% normal goat serum), slides were incubated overnight with goat polyclonal antibody raised against the carboxy terminus of orexin-A of human origin (identical to corresponding mouse sequence). The antibody was purchased from Santa Cruz Biotechnology, Inc. (sc-8070). Antibody binding was detected using biotinylated secondary antibodies (Vector Laboratories).
For measuring orexin A levels as described previously (22), brains from 7-weeks old mice (three B6-tub/tub and three B6-+/+) were collected during the late light period and immediately frozen in liquid nitrogen, then weighed. The tissue samples were boiled in 2 ml of Milli-Q water for 10 min.
After cooling on ice, acetic acid and HCL were added to a final concentration of 1M and 20 mM, respectively. After homogenization at 40,000 rpm for 1 min (Virtex tissue homogenizer), 2ml extraction buffer (1M acetic acid and 20 mM HCL) was added and the sample was centrifuged at 5,000xg for 20 min. The supernatant was stored at -80ºC. Orexin A levels in the brain extracts were measured using a commercially available EIA kit (Phoenix Pharmaceuticals, Belmont, CA) according to manufacturers protocol. 
Western Blot analysis
Metabolites
Blood was collected from the orbital sinus via heparinized capillary tubes, and plasma was obtained by centrifugation at 4000 rpm for 10 min (4ºC). Sampling times were between 10:00 and 11:00 am for non-fed samples, between 4:00 and 5:00 pm for light period samples, and between 8:00 and 9:00 pm for dark period samples.
Glycogen was extracted from liver using hot potassium hydroxide and ethanol precipitation (10) .
After acid hydrolysis, glucose levels were determined in the hydrolysate as above.
Plasma glucose and free fatty acid (FFA) levels were determined spectrophotometrically using a colorimetric assay (No.1383175, Roche Diagnostics, IN) or in a Beckman Coulter Synchron CX5
Delta chemistry analyzer (Beckman Coulter Inc., CA).
Beta-hydroxybutrate levels were determined in duplicate using a spectrophotometric assay (No.310-A, Sigma, St. Louis, MO).
Pyruvate was extracted from liver using the methanol-chloroform-water (M/C) method (21) . The of extract in a total volume of 1.00 ml. The reaction mixtures for G6PD and GR were preincubated at 37ºC and 25ºC for 5 min in the absence of enzymes and substrate, respectively. The reaction was started by adding G6P and glutathione, and the reaction mixtures were incubated at 37ºC (G6PD) and 25ºC (GR) for 5 min. The absorbance of the mixture at 340 nm was measured at 340nm. A NADPH =A 1 -A 3, A NADP =A 2 -A 1.
ATP content was determined using luciferase assays (FL-AA) with reagents from Sigma Chemical (St.Louis, MO). All assays were performed in triplicate and included a concurrently run standard curve, according to the manufacturer's specifications.
Glutathione levels were determined by the dithionitrobezoic acid/glutathione reductase (GR)-recycling method of Tietze (42) . For determination of GSSG, the same recycling assay was performed in the presence of 2-vinylpyridine. The concentration of GSH and GSSG in the samples was calculated from a GSH standard curve.
Measurement of liver enzymes activities
All reagents and enzymes were obtained from Sigma Chemical Co. (St.Louis, MO).
To determine Glucose-6-phosphate-dehydrogenase (G6PDH) activity, liver was homogenized in 9 volumes of ice-cold 0.15 M KCl. After centrifugation at 10,000 x g for 30 min, the supernatant was used to determine G6PDH activities. Liver G6PDH activity was measured spectrophotometrically at 340 nm monitoring the reduction of NADP+ in the presence of glucose-6-phosphate (No.345-UV).
To determine Phosphofructokinase (PFK) activity, liver was homogenized in 2 ml of lysis buffer (20 mM Tris-Cl (pH7.5), 10 mM NaF, 10mM (NH 4 ) 2 SO 4 ,5 mM MgCl 2 , 2 mM EDTA, 2 mM aminocaproic acid, 10 mM DTT, 0.1 mM fructose-6-phosphate (F-6-P), 0.07 units/ml aprotonin, 0.2 mg/ml PMSF, 0.5% NP-40). The homogenate was centrifuged at 10,000xg at 4 ºC for 10 min, and aliquots of the supernatant were used for the determination of PFK activity. PFK activity was PG-00239-2005.R1 assayed at RT by adding 5-15 µl of liver extract to 300 µl reaction mix buffer (100 mM Tris-Cl (pH 8.0), 10 mM KCl, 5 mM MgCl 2, 5mM (NH 4 ) 2 SO 4, 1mM EDTA, 5mM DTT, 0.4 mg/ml BSA, 0.14 mg/ml NADH, 2 mM F-6-P, 1mM ATP, 1.5 units/ml aldolase, 5 units/ml triose-phosphate isomerase, 1 unit/ml alpha-glycerophosphate dehydrogenase (4). The changes in absorption by NADH were followed at 340 nm. Reaction rates reached maximal values 6-8 min after the initiation and persisted for another 6-8 min, during which time the data were collected.
Glucose-6-phosphatase (G6Pase) activity was measured colorimetrically at a wavelength of 660 nm as described (9) . The reaction rate was determined by measuring the increase in phosphate released from 30 mM Glucose-6-phosphate during a 15 min reaction time.
Pyruvate dehydrogenase (PDH) activity was determined by the method of Nakai et al. (28).
Briefly, approximately 100 mg liver was homogenized in an extraction buffer containing 50 mM HEPES (pH 7.4 with KOH), 3% Triton X-100, 2 mM EDTA, 5 mM dithiothreitol. 0.5 mM thiamine pyrophosphate, 2 mM dichloroacetate (PDH kinase inhibitor), 2 % bovine serum, 0.1 mM N-tosyl-lphenylalanine chloromethyl ketone, 0.1 mg/ml trypsin inhibitor, and 0.02 mg/ml leupeptin. The homogenate was divided into two portions for assaying actual (active dephosphorylated enzyme in the presence of inactive phosphorylated enzyme) and total (all enzyme in the dephosphorylated active form) activities. For determination of the actual activity, 50 mM potassium fluoride was immediately added and the homogenate centrifuged at 12,000 x g for 10 minutes. The supernatant obtained was used for the assay of actual activity. For measurement of total activity, the supernatant without potassium fluoride was centrifuged at 12,000 x g for 10 minutes and the PDH complex in the supernatant was activated for 20 minutes at 30 ºC after adding phosphoprotein phosphatase and 10 
Protein determination
The concentration of protein in homogenates was determined by the method of Lowry et al. using
bovine serum albumin as a standard (24) .
Statistical Analysis
All of the statistical analyses were conducted in JMP (v. 
Results
Tubby mice have an abnormally low respiratory exchange ratio in both fed and non-fed states
The Comprehensive Lab Animal Monitoring System (CLAMS TM ) is a mouse caging system with integrated instrumentation that allows for 24 hour automated data collection on individual mice.
Monitored are feeding, drinking, exploratory, ambulatory and rearing activity, as well as oxygen consumption and CO 2 production. In order to test the performance of the system in detecting mutant mice, 7-8 week old C57BL/6J.Cg-Tub tub /Tub tub (B6-tub/tub) mice and litter mate controls were used because tubby mice are not visibly distinguishable from their normal littermates or from C57BL/6 (B6) control mice at this early age. They also do not differ from controls in body weight until 12-16 weeks of age (1). Ten potential tubby mutants (genotype unknown) were placed in CLAMS TM cages at 7-8 weeks of age. Examination of collected data led to the classification of four mice as potential mutants, based primarily on their lower CO 2 production and their lower respiratory quotient compared to B6 control mice. All the mice were then genotyped and the four deviants were found to be homozygous for the tub mutation, whereas two other animals were heterozygous and four homozygous wild type, respectively. Fig. 1 shows that amounts and patterns of activity in a tubby mouse are generally similar to those of the normal B6 mouse ( Fig. 1 A and B) . O 2 consumption and CO 2 production of the B6 mouse parallels activity levels ( Fig. 1 A and C) In tubby mice ( Fig.1 B and D) average O 2 consumption is lower than in B6 mice, most notably during high activity (in the dark period). Shortly after entering the dark period (around 19:00 hrs) O 2 consumption is similar to that in B6. On the other hand, CO 2 production is always lower in tubby mice compared to B6 regardless of activity levels (light and dark). Consequently, the respiratory quotient in tubby mice is lower than in B6 mice and does not increase after transition to the dark cycle. Fig.2 shows the values for O 2 consumption (Fig. 2 A) , CO 2 production (Fig.2 B) , respiratory quotient (Fig. 2 D) , and ambulation ( Averaged over the entire light and dark periods, tubby mice had a tendency toward lower food intake than their littermate controls in the 4% standard diet (Fig.2 E) , particularly during the light period, although this difference reached only significance for females during the light period (p<0.0001).
Tubby mice also showed a trend toward lower activity levels (Fig.2 F) , again this only reached significance for females in the light period (p<0.0003).
Gene expression of key enzymes analyzed by real time quantitative RT-PCR
In order to gain initial insights into the causes for the low RQ in tubby homozygous mice, we examined mRNA levels for key metabolic genes across the light/dark transition. We focused on liver because of its role in carbohydrate metabolism. Real-time kinetic quantitative PCR was used to determine mRNA levels for selected genes in glycolytic, gluconeogenic, lipolytic and lipogenic pathways that had been reported in the literature to show diurnal rhythms in expression(13, 27, 44), with maximal expression levels between 22.00 and 06.00 hours, and minimal expression levels between 14.00 and 18.00 hours. Based on these published periods and the activity and feeding patterns obtained from our CLAMS data, we selected 16.00 to 17.00 hours to collect the light period samples and 23.00 to 24.00 hours for the dark period samples. The relative expression levels comparing tubby to B6 mice during light and dark periods are presented in Fig.3 .
The majority of the genes studied showed aberrant expression in tubby mice. While mRNA expression levels for representative enzymes that are active in glucose uptake (glucokinase, GK), glycolysis (phosphofructokinase, PFK), gluconeogenesis (phosphoenol pyruvate carboxy kinase, PEPCK), and lipogenesis (fatty acid synthase, FAS) were comparable to B6, genes in the lipolytic pathway showed regulation consistent with continued activity through the dark period ( Fig.3E-K) . At the same time these genes are down-regulated in tubby mice during the light period compared to B6.
Examples for this mRNA pattern are isocitrate dehydrogenase (IDH, Fig.3H ), acetyl-CoA synthetase (ACS, Fig.3E ), and carnitine palmitoyltransferase (CPT1, Fig.3F ). The genes in the tricarboxylic acid (TCA) cycle were down-regulated during the light period in tubby mice compared to B6 controls, when food intake was slightly lower in tubby mice. During the dark period, where food intake was comparable, the TCA cycle genes showed higher expression in tubby mice than in B6 controls (Fig.3P) .
We analyzed the normalized Ct values for each selected gene using the two-way ANOVA method including genotype (B6-+/+, B6-tub/tub), condition (dark/light), and their interactions in the model (supplemental material). ANOVA analyses indicated a significant main effect of condition on gene expression level for the genes encoding ACS, Agrp, FAS, G6PDH, and PEPCK (P<0.0001), and for genes GK and IDH (P<0.005). ANOVA analyses also indicated a significant main effect of genotype Fig.3 , where Ct values were converted to fold differences in expression, in order to illustrate the true changes.
The most dramatic dysregulation in tubby mice was seen for glucose-6-phosphate dehydrogenase (G6PDH). While G6PDH mRNA showed comparable very low expression in the light period in both mouse strains, it is highly induced in B6 mice after the onset of feeding, whereas it fails to be induced in tubby mice (p< 0.00001, Fig.3L ). This failure to induce G6PDH mRNA leads to a 46% reduction in protein levels as ascertained by western analysis, and a concomitant 34% reduction of liver enzyme activity compared to B6 mice (Table 2) .
Liver enzyme activities and metabolites
In the analysis of liver enzyme activities and metabolite concentrations, two-way ANOVA was performed to access the significance of the main effect factors, genotype (B6-+/+, B6-tub/tub) and condition (dark/light), and of their interactions. The ANOVA analyses revealed a significant main effect of condition to increased activities during the dark period. For the factor genotype, its effect averaged over light and dark periods is significant for the plasma levels of FFA (P<0.01) and ß-HBA and the enzyme activities of PFK (P<0.001), and G6PDH (P<0.0001). The interactions between genotype and condition were significant for G6PDH, PFK, and PDH-actual activity (P<0.01). For all the metabolite and liver enzymes under investigation, Student's t-tests were conducted to compare B6 PG-00239-2005.R1 to tubby mice during light and dark periods separately; and the p-values obtained from t-tests are summarized in table 2 along with means ± SEM for each group.
The greater reliance of tubby mice on fat metabolism for energy needs would be expected to be reflected in higher ketone body production. Plasma levels of ß-hydroxy-butyric acid (B-HBA) as a measure for ketone body formation were significantly higher in tubby mice compared to B6 controls ( 
Tubby mice show abnormal expression of hypothalamic neuropeptides
Because Tub is not expressed in liver (32), but has prominent expression in the central nervous system, we investigated the expression of key hypothalamic neuropeptides and proteins as possible mediators of the abnormal regulation of liver metabolism in tubby mice. Quantitative Real Time PCR analysis showed that neuropeptide Y (Npy), agouti related protein (Agrp), and preproorexin (Hcrt) were up-regulated between 3 and 64 fold both in the light as well as in the dark period, compared to B6 controls (Fig.3 M, N and O) . The higher expression levels of Hcrt in tubby mice, lead to higher levels of orexin protein in the cell bodies of orexin neurons in the lateral hypothalamus as determined by immunohistochemistry (Fig.4) . Quantitation by western analysis showed that orexin protein levels in brain extracts from tubby mice at 16:00 hr were significantly higher than from B6 mice (178.3±26 SE ng/g (n=3) vs 51.9±1.7 SE ng/g (n=3), p<0.0086, Fig.4 ). increase their food intake as they age (Nishina and Naggert, unpublished observation), their food intake surpasses that of control littermates only after the tubby mice weigh significantly more. The increase in food intake in older tubby mice may, therefore, reflect higher energy requirements to maintain the increased body mass (40) .
Because the liver is the most oxygen consuming organ in mammals in the resting state (29) and is thought to play a role in the systemic control of glucose and lipid utilization (20), we focused on gene expression and metabolic measurements in the liver. However, similar patterns of substrate utilization are expected to occur in other tissues as well. If glucose were used as energy source to a significant extent in other tissues such as in adipose tissue or muscle, then an increase in RQ should PG-00239-2005.R1 have been observed during the light/dark transition.
A large fraction (77%) of the genes whose mRNA levels were measured showed abnormalities in diurnal pattern and/or levels of expression. These abnormalities are already present prior to the onset of obesity in the tubby mice. Fig. 5 summarizes our findings. Genes in the fatty oxidation pathway are down regulated (relative to B6) during the light cycle, perhaps reflecting the reduced food intake during this period. However, during the dark period when food intake in tubby mice is similar to that in control mice, carnitine-acyl-transferase I (CPTI) which controls mitochondrial uptake of fatty acids for ß-oxidation, and acetyl-CoA-synthase, which activates the end product of ß-oxidation, are upregulated in tubby mice. Genes in the tricarboxylic acid cycle (TCA) through which the acetyl groups are oxidized, show a similar pattern of down-regulation during the day and up-regulation at night. These changes may be expected if, as hypothesized, fatty acid oxidation is the main source of energy during the dark period in tubby mice. It is interesting to note that in C.elegans worm carrying a mutation in the tub-1 gene, ß-oxidation also serves to limit lipid accumulation, since a mutation in the beta-oxidation pathway enzyme 3-ketoacyl-coA thiolase interacts with the tub-1 mutation to impair ß-oxidation and increase fat storage (26) .
Genes in the glycolytic pathway either show the same pattern of regulation as in B6 mice, or like pyruvate kinase (PK) as well as the rate limiting enzyme for glycolysis, pyruvate dehydrogenase (PDH) are up-regulated in the dark period compared to B6. Since the respiratory quotient in tubby mice does not rise in the dark period it appears that glycolysis has to be inhibited post translationally in tubby mice because glycogen content is markedly increased. Indeed, the activities of key regulatory enzymes in the glycolytic pathway such as phosphofructo-kinase (PFK) and PDH are lower in tubby mice, both during the light and dark cycle ( Table 2 ).
In addition, it is possible that a higher level of ß-oxidation could lead to increased levels of acetyl-CoA, which would feedback inhibit PDH and thus reduce glycolysis. Increased acetyl-CoA PG-00239-2005.R1
could then be available for de novo synthesis of fatty acids or ketone bodies. As expected, we do find increased levels of plasma ketone bodies in tubby mice, even in the light period. A reduction in glycolysis would also be expected to leave increased levels of glucose for storage. Again we find higher levels of liver glycogen in tubby mice at the end of the light period when these stores should be largely depleted.
An unexpected finding was the down-regulation of G6PDH and the complete lack of G6PDH induction in the dark period. G6PDH is the key regulating enzyme in the pentose-phosphate pathway, whose main functions are to supply reducing equivalents in the form of nicotinamideadenine dinucleotide phosphate (NADPH) for the de novo synthesis of fatty acids and for the maintenance of intra cellular reduced glutathione (GSH) concentrations. Perhaps as a consequence of the lack of G6PDH induction in tubby mice, reduced glutathione and NADPH levels are lower than those in B6 mice during the dark period. However, the ratio of NADPH/NADP + is similar in B6 and B6-tub/tub. Additional NADPH can be generated by the pentose phosphate pathway itself through conversion of the 5-carbon sugar via transaldolase/transketolase reactions to fructose-6-phosphate, which can then reenter the pathway. NADPH can also be generated by alternate routes, for example in the malic enzyme catalyzed reaction converting malate to pyruvate concomitant with a reduction of NADP+ to NADPH. Lower production of NADPH via the pentose-phosphate pathway and lower levels of pyruvate in tubby mice would favor this reaction to provide reducing equivalents for fatty acid synthesis. Another source for NADPH is the cytoplasmic conversion of citrate to a-keto glutarate by isocitrate dehydrogenase which is fed by shuttling citrate out of the mitochondrium in exchange for malate, and a-keto glutarate into the mitochondrium by transporting malate out again.
Isocitrate dehydrogenase as a source for NADPH has previously been shown to be important for fatty acid synthesis (18) .
Since up to thirty percent of liver glucose oxidation may occur via the pentose phosphate PG-00239-2005.R1 pathway (23, 43) , the failure to induce G6PDH in tubby mice contributes to their lower glucose utilization and RQ. Whether the lack of G6PDH induction is a direct effect of the tub mutation, a property of the genetic background, or secondary to the altered metabolic and hormonal environment in tubby mice is currently not known. Direct involvement of the TUB protein is, however, unlikely because of the very low expression of tub in liver. G6PDH is primarily regulated posttranscriptionally, i.e. following a stimulus mature mRNA is recruited to the cytoplasm after processing of a nuclear pre-mRNA pool (15, 36) . Insulin, glucose, and thyroid hormone induce mature G6PDH mRNA (36) , but the components of the signal transduction pathway are not known.
It is thought that the stimulatory effect of glucose (and fructose) is mediated by a glycolytic intermediate and insulin may act through stimulation of glycolysis (5). Reduced flux through the glycolytic pathway in tubby mice could, therefore, contribute to lower G6PDH levels.
The profound changes in liver metabolism in tubby mice are presumably the result of defects in central regulation since tub is expressed primarily in the central and peripheral nervous system and only at very low levels in the liver (32). However, the liver is innervated by both the sympathetic and parasympathetic nervous system. Transneuronal tracings show that neuronal populations in the lateral hypothalamic area, the ventromedial hypothalamic nucleus and the suprachiasmatic nucleus are retrogradely labeled (19) . It is also well known that sympathetic activity is correlated with fatty acid oxidation in peripheral tissues (38, 39) . In the search for potential central causes of the observed abnormalities in liver metabolism, we examined the expression of key neuropeptides and their receptors in the hypothalamus. The most notable difference between B6-tub/tub and B6 mice was a ~60 fold up-regulation of preproorexin mRNA. This up-regulation was also reflected in increased orexin A protein levels.
It has been previously shown that intra cerebro-ventricular injection of orexin A can lead to an increase in metabolic rate and a decrease in RQ depending on the metabolic state of the animal (25) . PG-00239-2005.R1 Similarly, electrical stimulation of the ventromedial hypothalamic nucleus (VMH) leads to increased basal metabolism and reduced RQ (35) . It may be important in this context that the orexin neurons of the LHA project to the VMH which in turn projects to the autonomic regions of the paraventricular nucleus thus providing a path for autonomic signals to the liver (19) . This suggests the hypothesis that the increase in orexin A in tubby mice is causative of the abnormal liver metabolism via the autonomic nervous system. It also appears from this work that the mutation in the tub gene primarily affects pathways leading to increased fat deposition, while leaving mechanisms resisting weight gain such as increased lipid oxidation intact. Tubby mice may, therefore, be a useful model system to further study the central regulation of energy metabolism. 
